NL285236A - - Google Patents

Info

Publication number
NL285236A
NL285236A NL285236DA NL285236A NL 285236 A NL285236 A NL 285236A NL 285236D A NL285236D A NL 285236DA NL 285236 A NL285236 A NL 285236A
Authority
NL
Netherlands
Application number
Publication of NL285236A publication Critical patent/NL285236A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
NL285236D NL285236A (da)

Publications (1)

Publication Number Publication Date
NL285236A true NL285236A (da)

Family

ID=1872579

Family Applications (1)

Application Number Title Priority Date Filing Date
NL285236D NL285236A (da)

Country Status (1)

Country Link
NL (1) NL285236A (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030199A2 (en) * 1979-12-03 1981-06-10 Merck & Co. Inc. Lyophilization process for live viral compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030199A2 (en) * 1979-12-03 1981-06-10 Merck & Co. Inc. Lyophilization process for live viral compositions
EP0030199A3 (en) * 1979-12-03 1982-06-09 Merck & Co. Inc. Lyophilization process for live viral compositions

Similar Documents

Publication Publication Date Title
US5792643A (en) Methods for preserving recombinant retroviruses
AU748296B2 (en) Stabilizers for lyophilized vaccines
US4273762A (en) Lyophilization process for live viral compositions
US3133861A (en) Attenuated live measles virus vaccine and method of production
DE2405675A1 (de) Verfahren zur inaktivierung von viren und die herstellung von vakzinen
US20130006563A1 (en) Continuous monitoring methods in vaccine production
FR2262M (da)
BE622212A (da)
NL285236A (da)